Register Login

ADC THERAPEUTICS SA (ADCT)

SymbolADCT
NameADC THERAPEUTICS SA
SectorHEALTH CARE
RegionEurope
IndustryBiotechnology: Pharmaceutical Preparations
AddressBIOPLE,ROUTE DE LA CORNICHE 3B, EPALINGES, 1066, Switzerland
Telephone+41 21 - 653 02 00
Fax—
Email—
Websitehttps://www.adctherapeutics.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK—
Description

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The companys product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

Additional info from NASDAQ:
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The companys product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

2026-04-20 10:03

New Form DEFA14A - ADC Therapeutics SA <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0000950103-26-005918 <b>Size:</b> 3 MB

Read more
2026-04-20 09:35

New Form DEF 14A - ADC Therapeutics SA <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001140361-26-015491 <b>Size:</b> 7 MB

Read more
2026-04-15 17:21

New Form 424B3 - ADC Therapeutics SA <b>Filed:</b> 2026-04-15 <b>AccNo:</b> 0000950103-26-005754 <b>Size:</b> 13 KB

Read more
2026-04-10 17:16

New Form PRE 14A - ADC Therapeutics SA <b>Filed:</b> 2026-04-10 <b>AccNo:</b> 0001140361-26-014246 <b>Size:</b> 7 MB

Read more
2026-04-06 22:47

New Form SCHEDULE 13G/A - ADC Therapeutics SA <b>Filed:</b> 2026-04-06 <b>AccNo:</b> 0001104659-26-040084 <b>Size:</b> 20 KB

Read more
2026-04-03 01:00

Redmile Group, LLC 🔴 sold 5.9M shares of ADC Therapeutics SA (ADCT) at $3.80 ($19.6M) Transaction Date: Mar 31, 2026 | Filing ID: 039359

Read more
2026-04-01 20:05

ADC Therapeutics Announces New Employee Inducement Grant

Read more
2026-03-17 07:03

New Form EFFECT - ADC Therapeutics SA <b>Filed:</b> 2026-03-16 <b>AccNo:</b> 9999999995-26-000834 <b>Size:</b> 1 KB

Read more
2026-03-10 17:46

New Form ARS - ADC Therapeutics SA <b>Filed:</b> 2026-03-10 <b>AccNo:</b> 0001628280-26-016511 <b>Size:</b> 59 MB

Read more
2026-03-10 17:39

New Form 10-K - ADC Therapeutics SA <b>Filed:</b> 2026-03-10 <b>AccNo:</b> 0001628280-26-016491 <b>Size:</b> 25 MB

Read more